Innovating Works

SAN ALF QUIMICAS

Inactiva
PanCareSurPass: PanCare studies of the scale up and implementation of the digital Survivorship Passport to improve p... SAN ALF QUIMICAS participó en un H2020: H2020-SC1-BHC-2018-2020 Almost 500,000 former childhood cancer patients (CCS) are now living in Europe. Compared to the general population, CCS represent a vulnerab...
2021-01-21 - 2025-02-28 | Financiado
CRUCIAL: MiCrovasculaR rarefaction in vascUlar Cognitive Impairement and heArt faiLure SAN ALF QUIMICAS participó en un H2020: H2020-SC1-BHC-2018-2020 Vascular dementia and heart failure represent major health burden to morbidity, mortality and quality of life. Comorbidities (hypertension,...
2019-12-06 - 2024-12-31 | Financiado
PROnecto: Enabling wide industrial take up of high performance nanomaterials SAN ALF QUIMICAS participó en un H2020: H2020-EIC-SMEInst-2018-2020 SPNano aims to set new standards for high-quality nanomaterial production and its wide industrial take up. We will path the way for enabling...
2018-05-12 - 2018-09-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.